Animal Health Institute
FDANonrulemakingFDA-2023-D-4761

International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products; Good Manufacturing Practice for Active Pharmaceutical Ingredients Used in Veterinary Medicinal Products; Draft Guidance for Industry; Availability

RIN
Last modified
Apr 2, 2024
Comment window
closed 855d ago
Animal Health Institute filings
1

Activity

Animal Health Institute filed 1 comment on this docket between Apr 2, 2024 and Apr 2, 2024. 0 other organizations filed here. The comment window closed 855d ago.

What Animal Health Institute filed (1)

Apr 2, 2024· Comment from Animal Health Institute (AHI)· FDA-2023-D-4761-0005

The Animal Health Institute (AHI) would like to thank FDA for their continued leadership in VICH. AHI supports the proposed guideline. The guideline will harmonize expectations during GMP inspections of facilities that manufacture APIs. Additionally, it allows manufacturers and regulators a framework to ensure that APIs meet the quality and purity characteristics they intend to possess. AHI received two comments from the animal health community. We are respectfully submitting them for consideration.

Abstract

OPEN

View on regulations.gov →
International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products; Good Manufacturing Practice for Active Pharmaceutical Ingredients Used in Veterinary Medicinal Products; Draft Guidance for Industry; Availability (FDA) — Animal Health Institute | OpenPolis